Irvine, CA, United States of America

Sari Mahon


Average Co-Inventor Count = 5.4

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Irvine, CA (US) (2019 - 2022)
  • La Jolla, CA (US) (2024)

Company Filing History:


Years Active: 2019-2024

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Sari Mahon: Innovator in Antidote Development

Introduction

Sari Mahon is a prominent inventor based in Irvine, CA, known for her significant contributions to the field of pharmaceutical compositions and antidote development. With a total of 4 patents, she has made remarkable strides in addressing critical health issues related to poisoning.

Latest Patents

Among her latest patents is a method and pharmaceutical composition for treating or preventing cyanide poisoning and/or methylmercaptan poisoning. This innovative approach involves administering tetrathionate to a subject in need, either through intramuscular injection or intranasal administration. Additionally, she has developed a method for detecting tetrathionate in a sample by reacting it with cyanide and measuring the resulting thiocyanate with ferric nitrate. Another notable patent involves methods and compositions for treating exposure to cyanide, sulfide, or methane-thiol, utilizing cobinamide compounds, such as amino-tetrazole-cobinamide and di-(amino-tetrazole)-cobinamide.

Career Highlights

Sari Mahon has worked with esteemed institutions, including the University of California and the University of Colorado. Her work has been instrumental in advancing the understanding and treatment of various poisoning scenarios.

Collaborations

Throughout her career, Sari has collaborated with notable colleagues, including Matthew D Brenner and Adriano Chan, contributing to the development of innovative solutions in her field.

Conclusion

Sari Mahon's work exemplifies the impact of innovation in the medical field, particularly in the development of antidotes for poisoning. Her contributions continue to pave the way for advancements in pharmaceutical treatments.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…